Literature DB >> 25223517

Underreporting of musculoskeletal disorders in 10 regions in France in 2009.

Stéphanie Rivière1, Emmanuelle Penven, Hélène Cadéac-Birman, Yves Roquelaure, Madeleine Valenty.   

Abstract

BACKGROUND: Underreporting of occupational diseases (OD) has been quantified, in particular in the United States, but little information is available in other countries. The aim of this study was to evaluate underreporting of musculoskeletal disorders (MSD) in France in 2009.
METHODS: We calculated an indicator that approximated the underreporting rate of MSD in 10 regions of France. Two databases were used: data on OD compensated by insurance funding and data from the surveillance program for uncompensated work-related diseases. Analyses were performed for carpal tunnel syndrome (CTS) and elbow, shoulder, and lumbar spine MSD.
RESULTS: The underreporting rate was estimated at 59% (range 52-64%) for CTS, 73% (range 67-79%) for elbow MSD, 69% (range 63-74%) for shoulder MSD, and 63% (range 50-76%) for lumbar spine MSD.
CONCLUSIONS: This study revealed that MSD are substantially underreported in France, as in the United States, despite the differences in workers' compensation systems.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  MSD; epidemiology; occupational disease; surveillance; work-related musculoskeletal disorders; workers' compensation

Mesh:

Year:  2014        PMID: 25223517     DOI: 10.1002/ajim.22364

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  2 in total

1.  Job Restrictions for Healthcare Workers with Musculoskeletal Disorders: Consequences from the Superior's Viewpoint.

Authors:  M Grataloup; A Massardier-Pilonchéry; A Bergeret; Jean-Baptiste Fassier
Journal:  J Occup Rehabil       Date:  2016-09

2.  Associations between Distal Upper Extremity Job Physical Factors and Psychosocial Measures in a Pooled Study.

Authors:  Matthew S Thiese; Kurt T Hegmann; Jay Kapellusch; Andrew Merryweather; Stephen Bao; Barbara Silverstein; Arun Garg
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.